Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 19/20 | 1.00 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.48 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28448066 | 0.92 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11PTGS1PTGS2 | |
| SCHEMBL28452091 | 0.89 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL28455331 | 0.88 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11PTGS1PTGS2 | |
| SCHEMBL28539083 | 0.87 | SLC22A12 (0.78) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL28449524 | 0.83 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11PTGS1PTGS2 | |
| SCHEMBL28454367 | 0.83 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL19240232 | 0.83 | SLC22A12 (0.70) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL19240225 | 0.81 | SLC22A12 (0.67) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL28445718 | 0.81 | SLC22A12 (1.00) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL28555603 | 0.80 | SLC22A12 (0.69) | SLC22A12SLC22A6SLC22A11ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106831556-B | Sulfonamide compound, preparation method thereof and application of sulfonamide compound as urate transporter inhibitor medicine | 成都海创药业有限公司 | 2020-09-01 | — | — | CN | disclosed |